vs
Apellis Pharmaceuticals, Inc.（APLS）与Otter Tail Corp（OTTR）财务数据对比。点击上方公司名可切换其他公司
Otter Tail Corp的季度营收约是Apellis Pharmaceuticals, Inc.的1.5倍（$308.1M vs $199.9M），Otter Tail Corp净利率更高（16.8% vs -29.5%，领先46.3%），Otter Tail Corp同比增速更快（1.6% vs -5.9%），Otter Tail Corp自由现金流更多（$22.3M vs $-14.3M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs -5.8%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Otter Tail公司是总部位于美国明尼苏达州弗格斯福尔斯的电力与制造企业，旗下拥有Otter Tail电力公司、BTD制造、T.O.塑料、北方管道产品以及Vinyltech等多家子公司，业务覆盖电力供应及多元制造领域。
APLS vs OTTR — 直观对比
营收规模更大
OTTR
是对方的1.5倍
$199.9M
营收增速更快
OTTR
高出7.6%
-5.9%
净利率更高
OTTR
高出46.3%
-29.5%
自由现金流更多
OTTR
多$36.6M
$-14.3M
两年增速更快
APLS
近两年复合增速
-5.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $308.1M |
| 净利润 | $-59.0M | $51.8M |
| 毛利率 | — | — |
| 营业利润率 | -25.6% | 21.9% |
| 净利率 | -29.5% | 16.8% |
| 营收同比 | -5.9% | 1.6% |
| 净利润同比 | -62.2% | -5.6% |
| 每股收益（稀释后） | $-0.40 | $1.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSOTTR
| Q4 25 | $199.9M | $308.1M | ||
| Q3 25 | $458.6M | $325.6M | ||
| Q2 25 | $178.5M | $333.0M | ||
| Q1 25 | $166.8M | $337.4M | ||
| Q4 24 | $212.5M | $303.1M | ||
| Q3 24 | $196.8M | $338.0M | ||
| Q2 24 | $199.7M | $342.3M | ||
| Q1 24 | $172.3M | $347.1M |
净利润APLSOTTR
| Q4 25 | $-59.0M | $51.8M | ||
| Q3 25 | $215.7M | $78.3M | ||
| Q2 25 | $-42.2M | $77.7M | ||
| Q1 25 | $-92.2M | $68.1M | ||
| Q4 24 | $-36.4M | $54.9M | ||
| Q3 24 | $-57.4M | $85.5M | ||
| Q2 24 | $-37.7M | $87.0M | ||
| Q1 24 | $-66.4M | $74.3M |
营业利润率APLSOTTR
| Q4 25 | -25.6% | 21.9% | ||
| Q3 25 | 48.7% | 29.7% | ||
| Q2 25 | -18.6% | 29.3% | ||
| Q1 25 | -50.0% | 24.9% | ||
| Q4 24 | -12.3% | 22.0% | ||
| Q3 24 | -24.0% | 31.8% | ||
| Q2 24 | -14.7% | 32.4% | ||
| Q1 24 | -36.0% | 27.4% |
净利率APLSOTTR
| Q4 25 | -29.5% | 16.8% | ||
| Q3 25 | 47.0% | 24.0% | ||
| Q2 25 | -23.6% | 23.3% | ||
| Q1 25 | -55.3% | 20.2% | ||
| Q4 24 | -17.1% | 18.1% | ||
| Q3 24 | -29.2% | 25.3% | ||
| Q2 24 | -18.9% | 25.4% | ||
| Q1 24 | -38.5% | 21.4% |
每股收益（稀释后）APLSOTTR
| Q4 25 | $-0.40 | $1.22 | ||
| Q3 25 | $1.67 | $1.86 | ||
| Q2 25 | $-0.33 | $1.85 | ||
| Q1 25 | $-0.74 | $1.62 | ||
| Q4 24 | $-0.30 | $1.30 | ||
| Q3 24 | $-0.46 | $2.03 | ||
| Q2 24 | $-0.30 | $2.07 | ||
| Q1 24 | $-0.54 | $1.77 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $440.5M |
| 总债务越低越好 | — | $963.6M |
| 股东权益账面价值 | $370.1M | $1.9B |
| 总资产 | $1.1B | $4.0B |
| 负债/权益比越低杠杆越低 | — | 0.52× |
8季度趋势，按日历期对齐
现金及短期投资APLSOTTR
| Q4 25 | $466.2M | $440.5M | ||
| Q3 25 | $479.2M | $379.7M | ||
| Q2 25 | $370.0M | $307.2M | ||
| Q1 25 | $358.4M | $284.8M | ||
| Q4 24 | $411.3M | $295.4M | ||
| Q3 24 | $396.9M | $280.0M | ||
| Q2 24 | $360.1M | $230.7M | ||
| Q1 24 | $325.9M | $238.2M |
总债务APLSOTTR
| Q4 25 | — | $963.6M | ||
| Q3 25 | — | $1.0B | ||
| Q2 25 | — | $1.0B | ||
| Q1 25 | — | $993.5M | ||
| Q4 24 | — | $943.7M | ||
| Q3 24 | — | $947.0M | ||
| Q2 24 | — | $947.0M | ||
| Q1 24 | $93.1M | $947.0M |
股东权益APLSOTTR
| Q4 25 | $370.1M | $1.9B | ||
| Q3 25 | $401.2M | $1.8B | ||
| Q2 25 | $156.3M | $1.8B | ||
| Q1 25 | $164.2M | $1.7B | ||
| Q4 24 | $228.5M | $1.7B | ||
| Q3 24 | $237.1M | $1.6B | ||
| Q2 24 | $264.3M | $1.6B | ||
| Q1 24 | $266.7M | $1.5B |
总资产APLSOTTR
| Q4 25 | $1.1B | $4.0B | ||
| Q3 25 | $1.1B | $3.8B | ||
| Q2 25 | $821.4M | $3.8B | ||
| Q1 25 | $807.3M | $3.7B | ||
| Q4 24 | $885.1M | $3.7B | ||
| Q3 24 | $901.9M | $3.6B | ||
| Q2 24 | $904.5M | $3.5B | ||
| Q1 24 | $831.9M | $3.3B |
负债/权益比APLSOTTR
| Q4 25 | — | 0.52× | ||
| Q3 25 | — | 0.57× | ||
| Q2 25 | — | 0.59× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.57× | ||
| Q3 24 | — | 0.58× | ||
| Q2 24 | — | 0.60× | ||
| Q1 24 | 0.35× | 0.63× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $97.0M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $22.3M |
| 自由现金流率自由现金流/营收 | -7.1% | 7.2% |
| 资本支出强度资本支出/营收 | 0.1% | 24.3% |
| 现金转化率经营现金流/净利润 | — | 1.87× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $97.9M |
8季度趋势，按日历期对齐
经营现金流APLSOTTR
| Q4 25 | $-14.2M | $97.0M | ||
| Q3 25 | $108.5M | $129.6M | ||
| Q2 25 | $4.4M | $119.9M | ||
| Q1 25 | $-53.4M | $39.5M | ||
| Q4 24 | $19.4M | $130.0M | ||
| Q3 24 | $34.1M | $99.3M | ||
| Q2 24 | $-8.3M | $151.5M | ||
| Q1 24 | $-133.0M | $71.9M |
自由现金流APLSOTTR
| Q4 25 | $-14.3M | $22.3M | ||
| Q3 25 | $108.3M | $40.5M | ||
| Q2 25 | $4.4M | $53.7M | ||
| Q1 25 | $-53.4M | $-18.5M | ||
| Q4 24 | $19.3M | $31.1M | ||
| Q3 24 | — | $15.1M | ||
| Q2 24 | $-8.4M | $50.1M | ||
| Q1 24 | $-133.3M | $-2.1M |
自由现金流率APLSOTTR
| Q4 25 | -7.1% | 7.2% | ||
| Q3 25 | 23.6% | 12.4% | ||
| Q2 25 | 2.5% | 16.1% | ||
| Q1 25 | -32.0% | -5.5% | ||
| Q4 24 | 9.1% | 10.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | -4.2% | 14.6% | ||
| Q1 24 | -77.3% | -0.6% |
资本支出强度APLSOTTR
| Q4 25 | 0.1% | 24.3% | ||
| Q3 25 | 0.0% | 27.4% | ||
| Q2 25 | 0.0% | 19.9% | ||
| Q1 25 | 0.0% | 17.2% | ||
| Q4 24 | 0.0% | 32.6% | ||
| Q3 24 | 0.0% | 24.9% | ||
| Q2 24 | 0.0% | 29.6% | ||
| Q1 24 | 0.2% | 21.3% |
现金转化率APLSOTTR
| Q4 25 | — | 1.87× | ||
| Q3 25 | 0.50× | 1.65× | ||
| Q2 25 | — | 1.54× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 2.37× | ||
| Q3 24 | — | 1.16× | ||
| Q2 24 | — | 1.74× | ||
| Q1 24 | — | 0.97× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
OTTR
| Retail Commercial And Industrial | $91.0M | 30% |
| Plastics | $81.2M | 26% |
| Manufacturing | $77.2M | 25% |
| Retail Residential | $35.8M | 12% |
| Electric Transmission | $14.4M | 5% |
| Plastic Products | $9.2M | 3% |
| Electric Product Other | $1.8M | 1% |
